To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers

Exclusion Criteria

• •Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (but excluding untreated, asymptomatic, seasonal allergies at time of dosing)
• •Any condition possibly affecting drug absorption, distribution, metabolism, and excretion (e.g. gastrectomy)
• •Twofold or more than upper limit of normal range in laboratory test for ALT or AST
• •Participating in other clinical trial study within 2 month preceding the first dose of investigational product
• •History of significant alcohol abuse or drug abuse within one year prior to the screening
• •Whole blood donation within 2 months prior to dosing, or apheresis donation within 1 month prior to dosing
• •Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the subject inappropriate for entry into this study
• •Unwilling or unable to comply with the lifestyle guidelines described in this protocol
• •Subjects who are inadequate for this study to participate judged by investigator